Status:
ACTIVE_NOT_RECRUITING
Efficacy of Extra Virgin Olive Oil (EVOO) Supplementation on Hand-Foot Syndrome Incidence in Patients With Capecitabine
Lead Sponsor:
Universitas Sriwijaya
Conditions:
Hand and Foot Skin Reaction
Hand and Foot Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The study was aimed to evaluate the efficacy of extra virgin olive oil (EVOO) supplementation compared to placebo to prevent HFS by observing changes in serum COX 2, malondialdehyde (MDA), and TNF α l...
Eligibility Criteria
Inclusion
- Patients pathologically and clinically diagnosed with III or IV stadium of breast cancer or colorectal cancer.
- fully recovered after curative resection within 8 weeks
- receive adjuvant capecitabine based chemotherapy
Exclusion
- did not meet the eligibility criteria for chemotherapy
- had previous allergy with capecitabine or olive oil
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06188000
Start Date
January 1 2023
End Date
February 20 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rumah Sakit Mohammad Hoesin
Palembang, South Sumatera, Indonesia, 30126